Activity of Diphenyleneiodonium toward Multidrug-Resistant Strains.

Gut Liver

Department of Convergence Medicine and Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Published: September 2017

Background/aims: The increased resistance of to antibiotics has increased the need to develop new treatments for this bacterium. The aim of our study was to identify new drugs with anti- activity.

Methods: We screened a small molecule library-the library of pharmacologically active compounds (LOPAC), which includes 1,280 pharmacologically active compounds-to identify inhibitors of growth. The minimal inhibitory concentrations (MICs) of antibiotics against multidrug-resistant strains were determined using the agar dilution method.

Results: We identified diphenyleneiodonium (DPI) as a novel anti- agent. The MIC values for DPI were <0.03 µg/mL against all tested strains. DPI also exhibited strong antibacterial activity against common gram-negative and gram-positive pathogenic bacteria.

Conclusions: DPI may be a candidate anti- drug for future development.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593327PMC
http://dx.doi.org/10.5009/gnl16503DOI Listing

Publication Analysis

Top Keywords

multidrug-resistant strains
8
pharmacologically active
8
activity diphenyleneiodonium
4
diphenyleneiodonium multidrug-resistant
4
strains background/aims
4
background/aims increased
4
increased resistance
4
resistance antibiotics
4
antibiotics increased
4
increased develop
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!